Access to the PPM Journal and newsletters is FREE for clinicians.
9 Articles in Volume 6, Issue #2
Assessment and Treatment of Chronic Pain
Clinical Drug Testing for Pain Medicine
Epidural Indomethacin Alternative in Adult Onset Diabetics
Focus on Urine Drug Monitoring
Office-based Treatment of Opioid Physical Dependence
Oxycodone to Morphine Rotation
Pain Care at the End of Life
Tennant Blood Study, A Summary Report
The Psychiatric Model of Treating Chronic Pain

Tennant Blood Study, A Summary Report

For some time, the medical staff of Practical Pain Management have been aware of the fact that there is a dire need for a method of measuring the effectiveness, tolerance, and proper usage of prescribed opioids, and other aggressive drug therapies. To claim wrongdoing by pain physicians, arbitrary guidelines have been employed by prosecutors, litigants, and medical boards ranging from the total number of pills prescribed, the number of prescriptions, or blood levels to establish legality—all without consideration of the patient’s condition.

As a result, physicians are inhibited from properly prescribing opioids to chronic pain patients, stand the risk of prosecution and, in general, are unable to adequately fulfill their obligations to their patients.

The author has believed that a correlation between blood level concentrations and proper prescribing could be developed. To do this, Practical Pain Management solicited readers in December 2005, to participate in a survey in which they would submit blood level concentrations and select conditions of patients. The following sections describe the methodology, patient descriptions, major problems addressed, results, and conclusions. Ultimately, it is a goal of this publication to develop guidelines that will protect physicians and permit them to minister to their patients to their fullest ability.

Goals for this Survey
This survey was undertaken to accomplish specific goals which are stated below:
1. To prevent the arbitrary application of published, therapeutic opioid blood levels in non-tolerant patients with acute or short term conditions (e.g. post operative or dental; see Table 1) to chronic pain patients who are tolerant and treated with high opioid dosages.
2. To prevent claims of over-prescribing by physicians based solely on an opioid blood level in situations where the patient has had an accident or has died.
3. To encourage physicians to use blood levels to help determine if opioid dosage is appropriate or if malabsorption or rapid metabolism may be present.
4. To encourage the use of opioid blood levels to help determine if tolerance to opioids is present (normal physiologic and mental function in the presence of a significant opioid blood level is diagnostic of opioid tolerance.)

Please refer to the March 2006 issue for the complete text.

Last updated on: January 7, 2021
close X